Fulphila (pegfilgrastim)

pCPA File Number: 22737

Negotiation Status:

Active Negotiation

Indication(s):

Febrile neutropenia in non-myeloid malignancies

Sponsor/Manufacturer:

BGP Pharma ULC

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2024-11-29

Negotiation Process Concluded:

Not Applicable